Skip to main content
# Title Research Year
211 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
212 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
213 Des-gamma Carboxy Prothrombin, Alpha-Feto Protein and Alpha-Feto Protein L3 in Patients with Cirrhosis and Hepatocellular Carcinoma. 2011
214 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
215 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
216 Extrapulmonary small cell carcinoma in prostate: Detection with
18F-FDG PET/CT
2010
217 Extrapulmonary small cell carcinoma in prostate: Detection with
18F-FDG PET/CT
2010
218 18F-FDG PET for Routine Posttreatment Surveillance in Oral and Oropharyngeal Squamous Cell Carcinoma 2010
219 Extrapulmonary small cell carcinoma in prostate: Detection with
18F-FDG PET/CT
2010
220 Extrapulmonary small cell carcinoma in prostate: Detection with 18F-FDG PET/CT 2010